Close Menu

Institute for Molecular Medicine Finland

Polygenic risk scores have the potential to impact cancer screening, autoimmune disease testing, and therapeutics development, but more diverse data is needed.

With UK Biobank and FinnGenn data, researchers tracked down rare changes in the angiopoietin-like 7 gene that coincide with lower glaucoma and intraocular pressure risk.

Using the free service, called Fingenious, researchers will be able to access genomic data generated by the country's FinnGen project, which aims to genotype 500,000 Finns by 2023.

Labcyte and the University of Helsinki's Institute for Molecular Medicine Finland have expanded their partnership to include multiple new applications.

The pharma company will analyze genomic and clinical data from 2 million individuals over the next 10 years to drive drug development across its entire portfolio. 

NEW YORK (GenomeWeb News) – Studies by two independent research teams published online yesterday in Nature Neuroscience suggest a single gene — the enzyme-coding gene called TOP3B — contributes to processes related to schizophrenia and to a syndrome associated with autism spectrum disord

NEW YORK (GenomeWeb News) – Labcyte said today that the Institute for Molecular Medicine Finland, known as FIMM, will use Labcyte's acoustic liquid handling technology in its small molecule-based personalized cancer medicine programs, under a new collaboration.

The company's Multiplexing Diagnostics division will use the arrayer to develop molecular tools, including protein biomarkers, to diagnose allergy and autoimmunity.

The program will consist of miniaturized RNAi screens, and in the future will include compound/drug arrays.

FIMM studies cancer, as well as cardiovascular, neuro-psychiatric and viral diseases, carries out translational research, and seeks to promote human health through research on personalized medicine.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.